Who invested in RevBio

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 1 month ago

Funding summaryUpdated 26 Oct 2026

$17Mraised across 2 rounds since 2025, from 2 sources

$2.2MGrant$15MRound

Latest round: Round, $15MOct 2026
Step-upi: 6.8×
Investors: 4

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026

$2.2MGrant$15MRound

First round: Grant, $2.2M
Biggest round: $15M
Between rounds: 12 months

The rounds

Oct 2026
Round$15M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $15M sold, first sale Oct 2026
Oct 2025
Grant$2.2M4 new
Source recordedSEC filing: $10M sold, first sale Apr 2023

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Grant2025Round2026

MassChallenge

National Institutes of Health

MedTech InnovatorNational Institute on Aging

Everyone who backed them

MassChallengeAccelerator1round

National Institutes of HealthGovernment1round

MedTech InnovatorAccelerator1round

National Institute on AgingVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list RevBio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.